The article describes our work to develop a liquid biopsy alongside other companies and laboratories in Madison and at the University of...

On July 1, Seungpyo Hong, PSD Professor, Director of Wisconsin Center for NanoBioSystems and cofounder of Capio Biosciences, will become...

Professor Seungpyo Hong's work with Capio Biosciences is one of six faculty projects getting a boost from State Economic Engagement and...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 -...

Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method...

Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving...

Capio Biosciences, an early stage biotechnology startup company developing a biopsy-free technology for capturing Circulating Tumor Cells...

BUILDING A MOLECULAR DIAGNOSTICS STARTUP FROM THE GROUND UP Download PDF

Seungpyo Hong, founder of the cancer diagnostic company and Madison startup Capio Biosciences, said he met with executives from Foxconn...

Jeff Buchanan | January 5th, 2017 In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors...

by Judy Newman | Wisconsin State Journal | Dec 31, 2016 Madison draws a startup from Chicago with a novel way to track cancer Judy...

A start-up company co-founded by UNC Lineberger researcher Andrew Wang, MD, has raised $2.9 million to commercialize a test designed to...